Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in

  News Archive

Promising New Therapeutic for Angiogenic Retinal Diseases
Friday, October 16, 2015
Research models show that a small peptide prevents the overgrowth of blood vessels in the eye's retina - and can be delivered in the form of eye drops.

PPD Awarded U.S. Army and BARDA Research Contracts
Friday, October 16, 2015
Providing clinical development and vaccine services.

Vaccine to Treat High Cholesterol
Thursday, October 15, 2015
A team of researchers at the University of New Mexico (UNM) and the National Institutes of Health (NIH) have developed a vaccine to treat high cholesterol.

enGene, Johnson & Johnson Collaborate
Thursday, October 15, 2015
enGene, Inc. has announced that it has entered into a definitive agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to develop and commercialize new therapies for inflammatory bowel disease (IBD).

Asterias Biotherapeutics, Cell Therapy Catapult Collaborate
Thursday, October 15, 2015
Asterias Biotherapeutics, Inc.has signed an agreement with the UK-based Cell Therapy Catapult to advance development of large scale manufacturing processes for AST-VAC2, Asterias’ allogeneic dendritic cell immunotherapy.

HIV Vaccine Human Trials Begin
Wednesday, October 14, 2015
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.

Destructive Disease Shows Potential as a Cancer Treatment
Wednesday, October 14, 2015
Scientists at the University of British Columbia, Vancouver Coastal Health and the BC Cancer Agency have discovered a protein from malaria that could one day help stop cancer in its tracks.

New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
Tuesday, October 13, 2015
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.

Almac Group Addresses Industry Demand For Multiparticulate Drug Products
Monday, October 12, 2015
In response to increasing client demand for multiparticulate drug delivery systems, Almac Group is providing fluid-bed processing and encapsulation services to its global partners from its UK development and commercial manufacturing facilities.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 1670

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos